Publications & Research Reports
Dr. M. Christopher Roebuck has authored 120+ publications & research reports over a 28+ year career in health economics—peer-reviewed articles in journals including Health Affairs, Medical Care, the American Economic Review, and The American Journal of Managed Care, alongside issue briefs, commissioned reports, and professional publications. The bibliography below is open access to browse: every entry links to its DOI or PubMed record where one exists, with no gate in the way.
The record is independently verifiable through his Google Scholar profile and ORCID record. A full curriculum vitae (PDF) is also available. If you would like a copy of a specific paper, use the Request Full Paper link beside any entry and we will respond within one business day. To discuss how this research applies to your question, see our health economics and outcomes research consulting services.
Peer-Reviewed Journal Articles and Book Chapters
Forthcoming
Roebuck, M.C., P. Fronstin, and T.A. Brennan. Forthcoming. “Divergent Cost Trends for Three Advanced Cancers, 2013-2022: A Commercial Claims Analysis.” American Journal of Managed Care.
2025
Roebuck, M.C. and C.E. Schmid II. 2025. “The Cure Hepatitis C Act of 2025: Critical Questions and Policy Design Considerations.” Health Affairs Forefront, December 12, 2025.
2023
Fronstin, P., M.C. Roebuck, and A.M. Fendrick. 2023. “The Cost Implications of the Braidwood Ruling for Enrollees and Plan Sponsors.” Health Affairs Forefront, June 26, 2023.
2022
Randhawa, N., A. Khalyfa, M. Khan, M.C. Roebuck, M. Inam, and K. Ayub. 2022. “Utilization of Antireflux Mucosectomy and Resection and Plication: A Novel Approach for the Management of Recurrent Gastroesophageal Reflux Disease after Prior Nissen Fundoplication or Transoral Incisionless Fundoplication.” Journal of Clinical Medicine 11:7141.
Randhawa, N., A. Khalyfa, R. Aslam, M.C. Roebuck, M. Inam, and K. Ayub. 2022. “Endoscopic Ultrasound-Guided Botox Injection for Refractory Anal Fissure.” Journal of Clinical Medicine 11:6207.
Roebuck, M.C. 2022. “Impact of Direct-Acting Antiviral Use for Chronic Hepatitis C on Health Care Costs in Medicaid: Economic Model Update.” American Journal of Managed Care 28(12):100-101.
2021
Dankwa-Mullan, I., J. George, M.C. Roebuck, J. Tkacz, V.C. Willis, F. Reyes, and Y. Arriaga. 2021. “Variations in Breast Cancer Surgical Treatment and Timing: Determinants and Disparities.” Breast Cancer Research and Treatment 188:259-272.
Haddad, T., J.M. Helgeson, K.E. Pomerleau, A.M. Preininger, M.C. Roebuck, I. Dankwa-Mullan, G.P. Jackson, and M.P. Goetz. 2021. “Accuracy of an Artificial Intelligence System for Cancer Clinical Trial Eligibility Screening: Retrospective Pilot Study.” JMIR Medical Informatics 9(3):e27767.
2020
Beck, J.T., M. Rammage, G.P. Jackson, A.M. Preininger, I. Dankwa-Mullan, M.C. Roebuck, A. Torres, H. Holtzen, S.E. Coverdill, M.P. Williamson, Q. Chau, K. Rhee, and M. Vinegra. 2020. “Artificial Intelligence Tool for Optimizing Eligibility Screening for Clinical Trials in a Large Community Cancer Center.” JCO Clinical Cancer Informatics 4:50-59.
Chen, P., T. Li, T. Sun, V.C. Willis, M.C. Roebuck, D.M. Bravata, X. Liu, Y.E. Arriaga, I. Dankwa-Mullan, and A. Wu. 2020. “Clinical Decision Support for High-Risk Stage II Colon Cancer: A Real-World Study of Treatment Concordance and Survival.” Diseases of the Colon and Rectum 63(10):1383-1392.
Xu, F., M-J. Sepulveda, Z. Jiang, H. Wang, J. Li, Z. Liu, Y. Yin, M.C. Roebuck, E.H. Shortliffe, M. Yan, Y. Song, C. Geng, J. Tang, G.P. Jackson, A. Preininger, and K. Rhee. 2020. “Effect of an Artificial Intelligence Advisory Tool on Treatment Decisions for Complex Breast Cancer.” JCO Clinical Cancer Informatics 4:824-838.
2019
Roebuck, M.C. and J.N. Liberman. 2019. “Assessing the Burden of Illness of Chronic Hepatitis C and Impact of Direct-Acting Antiviral Use on Healthcare Costs in Medicaid.” American Journal of Managed Care 25(8 Suppl):S131-S139.
Xu, F., M-J. Sepulveda, Z. Jiang, H. Wang, J. Li, Y. Yin, Z. Liu, M.C. Roebuck, E.H. Shortliffe, M. Yan, Y. Song, C. Geng, J. Tang, and K. Rhee. 2019. “Artificial Intelligence Treatment Decision Support for Complex Breast Cancer Among Oncologists with Varying Expertise.” JCO Clinical Cancer Informatics 1(3):1-15.
2018
2016
2015
2014
2013
Fronstin, P., M-J. Sepulveda, and M.C. Roebuck. 2013. “Consumer-Directed Health Plans Reduce the Long-Term Use of Outpatient Physician Visits and Prescription Drugs.” Health Affairs 32(6):1126-1134.
Fronstin, P., M-J. Sepulveda, and M.C. Roebuck. 2013. “Medication Utilization and Adherence in a Health Savings Account-Eligible Plan.” American Journal of Managed Care 19(12):e400-e407.
2012
Carls, G.S., M.C. Roebuck, T.A. Brennan, J.A. Slezak, O.S. Matlin, and T.B. Gibson. 2012. “Impact of Medication Adherence on Absenteeism and Short-Term Disability for Five Chronic Diseases.” Journal of Occupational and Environmental Medicine 54(7):792-805.
Frick, K.D., M.C. Roebuck, J.I. Feldstein, C.A. McCarty, and L.L. Grover. 2012. “Health Services Utilization and Cost of Retinitis Pigmentosa.” Archives of Ophthalmology 130(5):629-634.
Ketcham, J., C. Lucarelli, E. Miravete, and M.C. Roebuck. 2012. “Sinking, Swimming, or Learning to Swim in Medicare Part D.” American Economic Review 102(6):2639-2673.
Polinski, J.M., W.H. Shrank, R.J. Glynn, H.A. Huskamp, M.C. Roebuck, and S. Schneeweiss. 2012. “Association between the Part D Coverage Gap and Adverse Health Outcomes.” Journal of the American Geriatrics Society 60(8):1408-1417.
Polinski, J.M., W.H. Shrank, R.J. Glynn, H.A. Huskamp, M.C. Roebuck, and S. Schneeweiss. 2012. “Beneficiaries with Cardiovascular Disease and the Part D Coverage Gap.” Circulation: Cardiovascular Quality and Outcomes 5(3):387-395.
2011
2010
2009
2008
2005
Mundt, M.P., M.T. French, M.C. Roebuck, L.B. Manwell, and K.L. Barry. 2005. “Brief Physician Advice for Problem Drinking among Older Adults: An Economic Analysis of Costs and Benefits.” Journal of Studies on Alcohol 66(3):389-394.
Powers, C.A., C.M. Meyer, M.C. Roebuck, and B. Vaziri. 2005. “Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data: A Comparison of Alternative Econometric Cost Modeling Techniques.” Medical Care 43(11):1065-1072.
2004
French, M.T., M.C. Roebuck, and A.T. McLellan. 2004. “Cost Estimation When Time and Resources are Limited: The Brief DATCAP.” Journal of Substance Abuse Treatment 27(3):187-193.
French, M.T., M.C. Roebuck, and P.K. Alexandre. 2004. “To Test or Not to Test: Do Workplace Drug Testing Programs Really Discourage Employee Drug Use?" Social Science Research 33(1):45-63.
Roebuck, M.C., M.T. French, and M.L. Dennis. 2004. “Adolescent Marijuana Use and School Attendance.” Economics of Education Review 23(2):145-153.
2003
Alexandre, P.K., M.C. Roebuck, M.T. French, and M.J. Barry. 2003. “The Cost of Residential Addiction Treatment in Public Housing.” Journal of Substance Abuse Treatment 24(4):285-290.
French, M.T., M.C. Roebuck, M.L. Dennis, S.H. Godley, H.A. Liddle, and F.M. Tims. 2003. “Outpatient Marijuana Treatment for Adolescents: Economic Evaluation of a Multi-Site Field Experiment.” Evaluation Review 27(4):421-459.
Roebuck, M.C., M.T. French, and A.T. McLellan. 2003. “DATStats: Results from 85 Studies Using the Drug Abuse Cost Analysis Program (DATCAP).” Journal of Substance Abuse Treatment 25(1):51-57.
2002
Dennis, M.L., J.C. Titus, G. Diamond, J. Donaldson, S.H. Godley, F. Tims, C. Webb, Y. Kaminer, T.F. Babor, M.C. Roebuck, M.D. Godley, N. Hamilton, H. Liddle, C.K. Scott, and the CYT Steering Committee. 2002. “The Cannabis Youth Treatment (CYT) Experiment: Rationale, Study Design, and Analysis Plans.” Addiction 97(S1):16-34.
Dennis, M.L., T.F. Babor, M.C. Roebuck, and J. Donaldson. 2002. "Changing the Focus: The Case for Recognizing and Treating Cannabis Use Disorders." Addiction 97(S1):4-15.
French, M.T., M.C. Roebuck, M.L. Dennis, G. Diamond, S.H. Godley, F. Tims, C. Webb, and J.M. Herrell. 2002. “The Economic Cost of Outpatient Marijuana Treatment for Adolescents: Findings from a Multi-Site Field Experiment.” Addiction 97(S1):84-97.
2001
Alexandre, P.K., M.C. Roebuck, M.T. French, D.D. Chitwood, and C.B. McCoy. 2001. “Problem Drinking, Health Services Utilization, and the Cost of Medical Care.” In Recent Developments in Alcoholism, Volume 15, Services Research in the Era of Managed Care, Section III, Chapter 13, pp. 285-298. M. Galanter (Ed.). Kluwer Academic/Plenum Press, New York.
French, M.T., M.C. Roebuck, A.T. McLellan, and J.L. Sindelar. 2001. “Can the Treatment Services Review (TSR) Be Used to Estimate the Costs of Addiction and Ancillary Services?” Journal of Substance Abuse 12(4):341363.
French, M.T., M.C. Roebuck, and P.K. Alexandre. 2001. “Illicit Drug Use, Employment, and Labor Force Participation." Southern Economic Journal 68(2):349-368.
French, M.T., M.C. Roebuck, K.A. McGeary, D.D. Chitwood, and C.B. McCoy. 2001. “Using the Drug Abuse Screening Test (DAST-10) to Analyze Health Services Utilization and Cost for Substance Abusers in a Community-Based Setting.” Substance Use and Misuse 36(6):927-947.
White Papers, Abstracts, and Other Works
2025
Fronstin, P. and M.C. Roebuck. 2025. “What Employers Should Know About the Inflation Reduction Act and Drug Development.” EBRI Fast Facts #529, May 2025.
2024
Fronstin, P. and M.C. Roebuck. 2024. “HSAs Reduce Use of Outpatient Services and Prescription Drugs, Increase Use of Inpatient Services; Overall Spending Unaffected.” EBRI Fast Facts #506, June 2024.
Fronstin, P. and M.C. Roebuck. 2024. “HSAs Reduce Use of Outpatient Services and Prescription Drugs, Increase Use of Inpatient Services; Overall Spending Unaffected.” EBRI Issue Brief No. 605, April 2024.
Fronstin, P. and M.C. Roebuck. 2024. “Medication Adherence Improved After Employers Added Pre-Deductible Coverage in Response to Increased IRS Flexibility.” EBRI Fast Facts #509, July 2024.
Fronstin, P. and M.C. Roebuck. 2024. “The Impact of Expanding Pre-Deductible Coverage in HSA-Eligible Health Plans on Medication Adherence.” EBRI Issue Brief No. 611, June 2024.
Fronstin, P. and M.C. Roebuck. 2024. “Value-Based Pricing for Hospital Outpatient Services: A Demonstration That Merges Cost-Effectiveness Analysis with Real-World Cost Data.” EBRI Issue Brief No. 625, November 2024.
2023
Fronstin, P. and M.C. Roebuck. 2023. “Cost Differences for Physician-Administered Outpatient Drugs by Site of Treatment: State and Metropolitan Statistical Areas Variation.” EBRI Fast Facts #469, May 2023.
Fronstin, P. and M.C. Roebuck. 2023. “Imposing Cost Sharing on Preventive Services Significantly Impacts Expenditures for Eligible Enrollees but Does Not Substantially Reduce Aggregate Employer Health Care Spending: Implications of Braidwood Management Inc. v. Becerra.” EBRI Fast Facts #474, June 2023.
Fronstin, P. and M.C. Roebuck. 2023. “Location, Location, Location: Spending Differences for Biologic and Biosimilar Medications by Site of Treatment.” EBRI Issue Brief No. 585, June 2023.
Fronstin, P. and M.C. Roebuck. 2023. “Provider Markups on Biologics Are Doubling Costs for Employers and Minimizing Savings from Biosimilar Competition.” EBRI Fast Facts #479, August 2023.
Fronstin, P. and M.C. Roebuck. 2023. “Using Health Plan Design to Incentivize Medication Adherence Among Diabetics: Impact on Employer and Patient Spending.” EBRI Fast Facts #482, September 2023.
Randhawa, N., A. Khalyfa, M. Khan, M. Inamullah, M.C. Roebuck, and K. Ayub. 2023. “A Comparison of Patient Satisfaction and Healthcare Resource Use in Patients with Barrett’s Esophagus Using Confocal Laser Endomicroscopy Based Approach Versus Standard of Care.” Gastrointestinal Endoscopy 97(6):AB1088AB1089.
Urick, B.Y., M.C. Roebuck, L.Z. Marshall, S. Pessian, and P.P. Gleason. 2023. “Estimating Medical Cost Offsets from Continuous Adherence Improvement Using Commercially Insured Members’ Real-World Data.” Poster presented at the Academy of Managed Care Pharmacy 2023 Annual Meeting, San Antonio, TX, March 22, 2023.
Urick, B.Y., M.C. Roebuck, L.Z. Marshall, S. Pessian, and P.P. Gleason. 2023. “Estimating Medical Cost Offsets from Continuous Adherence Improvement Using Commercially Insured Members’ Real-World Data.” Poster presented at the Pharmacy Quality Alliance 2023 Annual Meeting, Nashville, TN, May 11, 2023.
Urick, B.Y., M.C. Roebuck, L.Z. Marshall, S. Pessian, and P.P. Gleason. 2023. “Measuring Medication Adherence Associated Medical Care Savings Using Commercially Insured Members’ Real-World Data.” Poster presented at the Academy of Managed Care Pharmacy 2023 Annual Meeting, San Antonio, TX, March 22, 2023.
2022
Fronstin, P. and M.C. Roebuck. 2022. “How Do High-Deductible Health Plans Affect Use of Health Care Services and Spending Among Enrollees with Mental Health Disorders?” EBRI Issue Brief No. 555, March 2022.
Fronstin, P. and M.C. Roebuck. 2022. “Switch to High-Deductible Health Plans Reduces Use of Health Care Services and Spending Among Enrollees with Mental Health Disorders.” EBRI Fast Facts #431, March 2022.
Fronstin, P. and M.C. Roebuck. 2022. “Use of Health Care Services for Mental Health Disorders and Spending Trends.” EBRI Issue Brief No. 569, September 2022.
Fronstin, P. and M.C. Roebuck. 2022. “What Is Driving Increased Spending on Mental Health Care Services?” EBRI Fast Facts #443, October 2022.
Fronstin, P., M.C. Roebuck, and A.M. Fendrick. 2022. “Limited Impact on Premiums of Expanding Pre-Deductible Coverage.” EBRI Fast Facts #441, August 2022.
Fronstin, P., M.C. Roebuck, and A.M. Fendrick. 2022. “Premium Impact of Expanding Pre-Deductible Coverage to Chronic Disease Management Medications in HSA-Eligible Health Plans.” EBRI Issue Brief No. 563, July 2022.
Fronstin, P., M.C. Roebuck, and A.M. Fendrick. 2022. “Premium Increases Are Low When Employers Add Pre-Deductible Coverage for Preventive Services in Response to Increased IRS Flexibility.” EBRI Fast Facts #437, June 2022.
Fronstin, P., M.C. Roebuck, and A.M. Fendrick. 2022. “The Impact of Covering Select Preventive Services on Employer Health Care Spending.” EBRI Fast Facts #444, October 2022.
Fronstin, P., M.C. Roebuck, and A.M. Fendrick. 2022. “The Impact of Expanding Pre-Deductible Coverage in HSA-Eligible Health Plans on Premiums.” EBRI Issue Brief No. 558, May 2022.
Randhawa, N., A. Khalyfa, M.C. Roebuck, and K. Ayub. 2022. “The Relationship Between Patient Satisfaction and Use of Healthcare Services in Patients With Barrett’s Esophagus Using Confocal Laser Endomicroscopy Versus Standard of Care.” American Journal of Gastroenterology 117:S1159.
2021
Arriaga, Y., J. Tkacz, M.C. Roebuck, J. George, V. Willis, and I. Dankwa-Mullan. 2021. “Factors Associated with Utilization of Post-Mastectomy Adjuvant Therapies in Privately Insured Female Patients with Early-Stage Invasive Breast Cancer.” Abstract. Cancer Research 81(13 Supplement):2617.
Fronstin, P. and M.C. Roebuck. 2021. “Evidence That Health Care Coinsurance Reduces Use of Certain Care More Than Copayments Do.” EBRI Fast Facts #376, January 2021.
Fronstin, P. and M.C. Roebuck. 2021. “Higher Lab Costs, Equivalent Value: Evaluating the Cost of Lab Services in Hospital Outpatient Departments, Physician Offices, and Stand-Alone Lab Facilities.” EBRI Fast Facts #393, April 2021.
Fronstin, P. and M.C. Roebuck. 2021. “Location, Location, Location: Cost Differences in Health Care Services by Site of Treatment—A Closer Look at Lab, Imaging, and Specialty Medications.” EBRI Issue Brief No. 525, February 2021.
Fronstin, P. and M.C. Roebuck. 2021. “Location, Location, Location: Spending Differences for Physician-Administered Outpatient Medications by Site of Treatment.” EBRI Issue Brief No. 536, August 2021.
Fronstin, P. and M.C. Roebuck. 2021. “Shifting from Hospital Outpatient Departments to Physician Offices Equates to Significant Cost Reductions.” EBRI Fast Facts #405, September 2021.
Fronstin, P. and M.C. Roebuck. 2021. “Spending Differences for Physician-Administered Outpatient Drugs by Site of Treatment Across Metropolitan Statistical Areas and States.” EBRI Fast Facts #408, October 2021.
2020
Dankwa-Mullan, I., M.C. Roebuck, J. Tkacz, and Y. Arriaga. 2020. “Determinants of Adjuvant Therapy Decisions Following Breast Conserving Surgery in Females with Early-Stage Breast Cancer: A Real-World Evidence Study.” Abstract. Academy Health Virtual Annual Research Meeting:402.
Dankwa-Mullan, I., M.C. Roebuck, J. Tkacz, J. George, F. Reyes, and Y. Arriaga. 2020. “Regional Disparities in Time to Treatment for Breast Conserving Surgery and Mastectomy in Women with Early-Stage Breast Cancer.” Abstract. Cancer Research 80(16 Supplement):4341.
Dankwa-Mullan, I., M.C. Roebuck, J. Tkacz, J. George, F. Reyes, Y. Arriaga, and G. Jackson. 2020. “Trends in and Determinants of Time to Primary Surgical Treatment for Females with Early Breast Cancer.” Abstract. The American Society of Breast Surgeons Official Proceedings, Volume XXI, 2020 Virtual Scientific Session:782814.
Dankwa-Mullan, I., M.C. Roebuck, J. Tkacz, O.M. Fayanju, Y. Ren, G. Jackson, and Y.E. Arriaga. 2020. “Disparities in Receipt of and Time to Adjuvant Therapy After Lumpectomy.” Abstract. Journal of Clinical Oncology 38(15 Supplement):534.
Dankwa-Mullan, I., M.M. McKillop, M. Solomon, A.M. Preininger, M.C. Roebuck, Y. Arriaga, J. George, G.P. Jackson, and B.R. South. 2020. “Identifying and Leveraging Public Data Sources with Structured Social Determinants of Health Information for Observational Health Research.” Oral Presentation. American Medical Informatics Association Virtual Annual Symposium:S89.
Fronstin, P. and M.C. Roebuck. 2020. “Managing Use of Health Care Services After People Satisfy Their Deductible: What Do Copayments and Coinsurance Do?” EBRI Issue Brief No. 519, November 2020.
Fronstin, P., M.C. Roebuck, and B.C. Stuart. 2020. “Higher Oncology Medicine Costs, Equivalent Value: Evaluating Treatment in Hospital Outpatient Departments vs. Physician Offices.” EBRI Fast Facts #345, February 2020.
Fronstin, P., M.C. Roebuck, and B.C. Stuart. 2020. “HOPD-Infused Oncology Medicines Markup by MSAs and State.” EBRI Fast Facts #351, April 2020.
Fronstin, P., M.C. Roebuck, and B.C. Stuart. 2020. “How Site-of-Treatment Markups for Infused Oncology Medications Drive Cost Differences Over Time.” EBRI Fast Facts #360, August 2020.
Fronstin, P., M.C. Roebuck, and B.C. Stuart. 2020. “Location, Location, Location: Cost Differences for Oncology Medicines Based on Site of Treatment.” EBRI Issue Brief No. 498, January 2020.
Fronstin, P., M.C. Roebuck, J.D. Buxbaum, and A.M. Fendrick. 2020. “Do People Choose Wisely After Satisfying Health Plan Deductibles? Evidence from the Use of Low-Value Health Care Services?” EBRI Issue Brief No. 516, October 2020.
Fronstin, P., M.C. Roebuck, J.D. Buxbaum, and A.M. Fendrick. 2020. “Use of Low-Value Health Care Services Rises After People Satisfy Health Plan Deductibles.” EBRI Fast Facts #373, December 2020.
George, J., J. Tkacz, M.C. Roebuck, F. Reyes, Y.E. Arriaga, G.P. Jackson, and I. Dankwa-Mullan. 2020. “Real-World Study of Factors Associated with Breast Conserving Surgery for Females Diagnosed with Early-Stage Breast Cancer.” Abstract. Journal of the National Comprehensive Care Network 18(3.5):HSR20-085.
2019
Fronstin, P. and M.C. Roebuck. 2019. “Do Accumulating HSA Balances Affect Use of Health Care Services and Spending?” EBRI Issue Brief No. 482, May 2019.
Fronstin, P. and M.C. Roebuck. 2019. “Do HSAs Affect Use of Health Care Services?” EBRI Fast Facts #330, June 2019.
Fronstin, P. and M.C. Roebuck. 2019. “Persistency in High-Cost Health Care Claims: It’s Where the Spending Is, Stupid.” EBRI Issue Brief No. 493, October 2019.
Roebuck, M.C., B.C. Stuart, J.S. Dougherty, and J. Vandigo. 2019. “How Much More Did Hospital Outpatient Departments Charge for Infused Chemotherapy Drugs Compared to Physician Practices in 2016?” Abstract. Academy Health Annual Research Meeting:B-431.
2018
Fronstin, P. and M.C. Roebuck. 2018. “The Impact of Health Status and Use of Health Care Services on Disenrollment From HSA-Eligible Health Plans.” EBRI Issue Brief No. 465, November 2018.
Fronstin, P. and M.C. Roebuck. 2018. “The Relationship Between Health Plan Type and Use of Specialty Medications.” EBRI Fast Facts #310, July 2018.
Fronstin, P. and M.C. Roebuck. 2018. “The Relationship Between Health Plan Type, Use of Specialty Medications, and Worker Productivity.” EBRI Issue Brief No. 454, July 2018.
Fronstin, P. and M.C. Roebuck. 2018. “Worker Productivity and Use of Specialty Medications.” EBRI Fast Facts #313, August 2018.
Jiang, Z., F. Xu, M-J. Sepulveda, J. Li, H. Wang, Z. Lui, Y. Yin, M. Yan, Y. Song, J. Guo, M.C. Roebuck, C. Geng, and J. Tang. 2018. “Concordance, Decision Impact and Guidelines Adherence Using Artificial Intelligence in High-Risk Breast Cancer.” Abstract. Journal of Clinical Oncology 36(15):e18566.
Roebuck, M.C. 2018. “Unintended Consequences of 340B Drug Pricing Program.” Memorandum. RxEconomics LLC.
Roebuck, M.C. and J.N. Liberman. 2018. “Burden of Illness of Chronic Hepatitis C in Medicaid.” Value in Health 21(S1):S83.
Sweetman, Q. Chau, M.P. Williamson, M. Vinegra, T.C. Haddad, and M.P. Goetz. 2018. “Clinical Performance Pilot Using Cognitive Computing for Clinical Trial Matching at Mayo Clinic.” Abstract. Journal of Clinical Oncology 36(15):e18598.
2017
Fronstin, P. and M.C. Roebuck. 2017. “Health Plan Switching: A Case Study—Implications for Private- and Public-Health Insurance Exchanges and Increased Health Plan Choice.” EBRI Issue Brief No. 432, March 2017.
Fronstin, P. and M.C. Roebuck. 2017. “The Impact of Offering Free Coverage on Enrollment Choice and Risk Selection in an HSA-Eligible Health Plan.” EBRI Issue Brief No. 435, July 2017.
2016
Fronstin, P. and M.C. Roebuck. 2016. “Impact of Workplace Wellness-Program Participation on Medication Adherence.” EBRI Notes Vol. 37, No. 1, January 2016.
Fronstin, P. and M.C. Roebuck. 2016. “The Impact of an HSA-Eligible Health Plan on Health Care Services Use and Spending by Worker Income.” EBRI Issue Brief No. 425, August 2016.
Roebuck, M.C. 2016. “Downstream Medical Cost Offsets in Medicare from Prescription Drug Use in Employer-Sponsored Insurance.” Value in Health 19(3):A270.
Roebuck, M.C. and J.S. Dougherty. 2016. “Impact of Medication Adherence on Hospitalization in Medicaid.” Value in Health 19(3):A9.
2015
Fronstin, P. and M.C. Roebuck. 2015. “Financial Incentives and Workplace Wellness-Program Participation.” EBRI Issue Brief No. 412, March 2015.
Fronstin, P. and M.C. Roebuck. 2015. “Financial Incentives, Workplace Wellness-Program Participation, and Utilization of Healthcare Services and Spending.” EBRI Issue Brief No. 417, August 2015.
2014
Fronstin, P. and M.C. Roebuck. 2014. “Brand-Name and Generic Prescription Drug Use After Adoption of a Full-Replacement, Consumer-Directed Health Plan with a Health Savings Account.” EBRI Notes Vol. 35, No. 3, March 2014.
Fronstin, P. and M.C. Roebuck. 2014. “Quality of Health Care After Adopting a Full-Replacement, High-Deductible Health Plan with a Health Savings Account: A Five-Year Study.” EBRI Issue Brief No. 404, September 2014.
Fronstin, P. and M.C. Roebuck. 2014. “Reference Pricing for Health Care Services: A New Twist on the Defined Contribution Concept in Employment-Based Health Benefits.” EBRI Issue Brief No. 398, April 2014.
Fronstin, P. and M.C. Roebuck. 2014. “The Cost of Spousal Health Coverage.” EBRI Notes Vol. 35, No. 1, January 2014.
Fronstin, P. and M.C. Roebuck. 2014. “The Costs of Spousal Health Coverage.” EBRI Fast Facts #266, January 2014.
2013
Fronstin, P. and M.C. Roebuck. 2013. “Health Care Spending after Adopting a Full-Replacement, High-Deductible Health Plan with a Health Savings Account: A Five-Year Study.” EBRI Issue Brief No. 388, July 2013.
Polinski, J.M., W.H. Shrank, R.J. Glynn, H.A. Huskamp, M.C. Roebuck, and S. Schneeweiss. 2013. “Response Letter to Eltonsy and Colleagues.” Journal of the American Geriatrics Society 61(5):848-849.
Roebuck, M.C., R. Kaestner, and E. Miravete. 2013. “Medicaid Drug Rebates in Medicare Part D Low-Income Subsidy: An Economic Analysis of the Proposed Policy and its Implications for Multiemployer Plans.” Pharmaceutical Industry Labor-Management Association (PILMA).
2011
Yoo, L., M.C. Roebuck, A.S. Flowers, M. Jay, T.J. Herron, and T. Vo. 2011. “Potential Financial Impacts of Aspirin as Primary Preventative Care.” Abstract. CVS Caremark.
2010
Ruetsch, C., M.C. Roebuck, and J.P. Tkacz. 2010. “Buprenorphine Adherence Among Insured Patients with Opioid Dependence: Impact on Health Services Utilization and Cost.” Poster presented at the 2010 American Academy of Addiction Psychiatry, Boca Raton, FL, December 2-5, 2010.
2006
Esposito, D., M.C. Roebuck, and M.W. Lewis. 2006. “Beneficiaries’ Out-of-Pocket Costs Under the Medicare Prescription Drug Benefit: Evidence from Medicare Discount Drug Card Claims Data.” Abstract. Value in Health 9(3):A146.
2005
Lee, P.J., M.C. Roebuck, and A. Flowers. 2005. “Impact of Titration Trend and Dosage Ranges on Adherence to Quetiapine Therapy in the Treatment of Bipolar Disorder.” Abstract. CVS Caremark.